Risk factors for treatment resistance and relapse of Chinese patients with MPO-ANCA-associated vasculitis
Sign Up to like & getrecommendations! Published in 2020 at "Clinical and Experimental Medicine"
DOI: 10.1007/s10238-020-00614-7
Abstract: Identification of risk factors for treatment resistance and relapse would be crucial to personalization therapy in patients with myeloperoxidase (MPO)-anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (MPO-AAV). Current evidence with regard to the risk factors for treatment… read more here.
Keywords: relapse; risk; resistance relapse; treatment resistance ... See more keywords